Hematology/Oncology

Top Story

Cost-effectiveness in CRC screening may depend on patient participation

Cost-effectiveness in CRC screening may depend on patient participation
September 29, 2016

Given equal participation rates, fecal immunochemical tests and colonoscopy are more effective and less expensive than multitarget stool DNA tests for average-risk colorectal cancer screening, according to the results of a simulation study.

However, the model showed that screening with a multitarget stool DNA (MT-sDNA) test — which is more sensitive but less specific than FIT, and has a higher cost per-test — may be cost-effective if substantially higher participation rates are achieved.

Meeting News CoverageVideo

VIDEO: Immunotherapies, antibodies show promise in treating lung cancer

September 29, 2016
The use of nivolumab both as monotherapy and in combination with ipilimumab demonstrates increased safety and efficacy in patients with small cell lung cancer, according…
In the Journals Plus

Most premenopausal women should not undergo oophorectomy due to risks for chronic health conditions

September 29, 2016
Premenopausal women who underwent bilateral oophorectomy demonstrated elevated risk for multiple chronic health conditions, according to results from a historical cohort…

New analyses support blocking Anthem-Cigna and Aetna-Humana mergers

September 29, 2016
Two new American Medical Association analyses support the blocking of the Anthem-Cigna and Aetna-Humana mergers. “The [American Medical Association] AMA analyses…
Meeting News Coverage

Radiation boost after whole breast radiation therapy for DCIS reduces local tumor recurrence

September 29, 2016
A radiation boost improved local control and reduced local tumor recurrence among patients with ductal carcinoma in situ who underwent whole breast radiation therapy…
More News Headlines »
CME

The Patient with Castration-resistant Prostate Cancer

No commercial support for this activity.

Castration-resistant prostate cancer (CRPC) is a heterogeneous condition that encompasses a continuum of disease…
More »
Video
Meeting News Coverage

VIDEO: Combination of anti-PD-1 inhibitors with new immune-modulators produces ‘exciting’ results in solid tumors

August 31, 2016
More »
Featured
At Issue: Breast Cancer Resource Center

At Issue: Breast Cancer Resource Center

CME

The Patient with Myelofibrosis

No commercial support for this activity.

Myelofibrosis is caused by abnormal stem cells in the bone marrow that cause the uncontrolled production of mature…
More »
Current Issues
View the Current Issue
HemOnc Today
morganatic-roan
morganatic-roan